Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - NEXTGEN HEALTHCARE, INC. | d260922d8k.htm |
Exhibit 99.1
SELECTED FINANCIAL DATA
The following selected financial data with respect to our consolidated statements of income data for each of the five years in the period ended March 31, 2011 and the consolidated balance sheet data as of the end of each such fiscal year are derived from our audited consolidated financial statements. The following information should be read in conjunction with our consolidated financial statements and the related notes thereto, our independent registered public accounting firms’ reports thereon and the other financial information included in Item 8 and in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the fiscal year ended March 31, 2011, which remain unchanged except that per share information for all periods has been revised to reflect the Company’s 2-for-1 stock split of its outstanding common stock effective October 26, 2011. The selected data in this section is not intended to replace the consolidated financial statements included in that report, except that share and per share information for all periods has been revised to reflect the 2-for-1 stock split.
Consolidated Financial Data
| Fiscal Year Ended March 31, | ||||||||||||||||||||
| 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||
| Statements of Income Data: |
||||||||||||||||||||
| Revenue |
$ | 353,363 | $ | 291,811 | $ | 245,515 | $ | 186,500 | $ | 157,165 | ||||||||||
| Cost of revenue |
127,482 | 110,807 | 88,890 | 62,501 | 50,784 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Gross profit |
225,881 | 181,004 | 156,625 | 123,999 | 106,381 | |||||||||||||||
| Selling, general and administrative |
108,310 | 86,951 | 69,410 | 53,260 | 45,337 | |||||||||||||||
| Research and development costs |
21,797 | 16,546 | 13,777 | 11,350 | 10,166 | |||||||||||||||
| Amortization of acquired intangible assets |
1,682 | 1,783 | 1,035 | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Income from operations |
94,092 | 75,724 | 72,403 | 59,389 | 50,878 | |||||||||||||||
| Interest income |
263 | 226 | 1,203 | 2,661 | 3,306 | |||||||||||||||
| Other income (expense), net |
61 | 268 | (279 | ) | 953 | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Income before provision for income taxes |
94,416 | 76,218 | 73,327 | 63,003 | 54,184 | |||||||||||||||
| Provision for income taxes |
32,810 | 27,839 | 27,208 | 22,925 | 20,952 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Net income |
$ | 61,606 | $ | 48,379 | $ | 46,119 | $ | 40,078 | $ | 33,232 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Basic net income per share |
$ | 1.06 | $ | 0.84 | $ | 0.82 | $ | 0.73 | $ | 0.62 | ||||||||||
| Diluted net income per share |
$ | 1.06 | $ | 0.84 | $ | 0.81 | $ | 0.72 | $ | 0.60 | ||||||||||
| Basic weighted average shares outstanding |
57,894 | 57,270 | 56,062 | 54,596 | 53,764 | |||||||||||||||
| Diluted weighted average shares outstanding |
58,236 | 57,592 | 56,792 | 55,540 | 55,100 | |||||||||||||||
| Dividends declared per common share |
$ | 0.625 | $ | 0.600 | $ | 0.575 | $ | 0.500 | $ | 0.500 | ||||||||||
| March
31, 2011 |
March
31, 2010 |
March
31, 2009 |
March
31, 2008 |
March
31, 2007 |
||||||||||||||||
| Balance Sheet Data: |
||||||||||||||||||||
| Cash and cash equivalents |
$ | 116,617 | $ | 84,611 | $ | 70,180 | $ | 59,046 | $ | 60,028 | ||||||||||
| Working capital |
$ | 145,758 | $ | 118,935 | $ | 98,980 | $ | 79,932 | $ | 76,616 | ||||||||||
| Total assets |
$ | 378,686 | $ | 310,180 | $ | 242,101 | $ | 187,908 | $ | 150,681 | ||||||||||
| Total liabilities |
$ | 154,016 | $ | 121,891 | $ | 86,534 | $ | 74,203 | $ | 59,435 | ||||||||||
| Total shareholders’ equity |
$ | 224,670 | $ | 188,289 | $ | 155,567 | $ | 113,705 | $ | 91,246 | ||||||||||